MediPharm Labs Logo
CA58504D1006
A2N7AA
MEDIF

MediPharm Labs

Loading quotes...

Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

  • MediPharm Labs Q1 2026: revenue falls, adjusted EBITDA positive for first time

    MediPharm Labs reported Q1 2026 revenue of CAD 9.0 million (‑16.7% year‑on‑year) but achieved a positive adjusted EBITDA of CAD 0.1 million. Net loss widened to CAD 0.9 million, gross margin was 37%. International revenue accounted for 51% of sales. The company plans annual savings of CAD 1.0 million through restructurings and holds CAD 9.9 million in cash. The stock rose 12.5% in pre-market trading after the results were released. » More on de.investing.com


  • MediPharm Labs beats Q4 revenue forecast by 5.79% and highlights international sales

    MediPharm Labs reported Q4 2025 revenue of CAD 14.06 million versus expected CAD 13.29 million (+5.79%) and an EPS of zero, in line with forecasts. The stock rose 7.69% in premarket trading. International medical cannabis sales contributed over 50% of total revenue; the fiscal year recorded revenue growth of 8% and an improved net loss position of CAD 8.3 million. The company emphasizes expansion into foreign markets and the expansion of EU‑GMP capacity for 2026. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics
In 2022, MediPharm Labs has already paid €0.0431 in dividends. The last payout was in April 2022.

Financials

In the last quarter, MediPharm Labs had revenue of €7.13m and net profit of €67.64k
(EUR) September 2026
YoY
Revenue 7.13m 1.74%
Gross profit 2.27m 44.56%
Net profit 67.64k 105.16%
EBITDA 243.99k 123.37%

Fundamentals

Metric Value
Market capitalization
€18.29m
Number of shares
427.18m
52-week high/low
€0.0692 - €0.0364
Dividends No
Beta
0.92
P/E ratio
-10.00
PEG ratio
-0.08
P/B ratio
0.78
P/S ratio
0.66

Company profile

MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. It formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. The company also provides GMP flower sourcing, packaging, and distribution services. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.

Name
MediPharm Labs
CEO
Greg Hunter
Headquarters Barrie, on
Canada
Website
IPO
04/03/2019
Employees 127

Ticker symbols

Exchange Symbol
Pnk
MEDIF
Toronto Stock Exchange
LABS.TO
Frankfurt
MLZ.F
DĂĽsseldorf
MLZ.DU
MĂĽnchen
MLZ.MU
🍪

Parqet  uses cookies. Learn more